The Pharmaceuticals segment is the core of Nippon Shinyaku's business, encompassing the research, development, manufacturing, and commercialization of a diverse portfolio of drugs. This segment focuses on various therapeutic areas, including urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, and gastrointestinal disorders. R&D activities involve drug discovery, preclinical studies, and clinical trials. The segment utilizes advanced technologies in drug formulation, delivery systems, and targeted therapies. Patient impact is addressed through the development of innovative treatments that improve patient outcomes and quality of life. Market positioning is strengthened by strategic partnerships and collaborations, particularly in rare diseases. Future opportunities lie in expanding the product pipeline and entering new markets. Regulatory and clinical aspects are crucial, with a focus on obtaining approvals from regulatory bodies worldwide.

The Functional Foods segment focuses on the development, manufacturing, and marketing of health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Research and development activities include the identification and formulation of functional ingredients with health benefits. The segment utilizes technologies related to food science, ingredient processing, and product formulation. The therapeutic areas covered include general health and wellness, with a focus on preventative health. Patient impact is addressed through the provision of nutritional supplements and functional foods that support overall health and well-being. Market positioning is achieved through product innovation and strategic partnerships with food manufacturers and distributors. Future opportunities include expanding the product line and exploring new markets. Regulatory aspects involve compliance with food safety regulations and health claims.